NASDAQ: BCLI       Brainstorm Cell
Last Price Today's Change   Day's Range   Trading Volume
2.78   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):51,351
4 Weeks Range:2.69 - 3.05
4 Weeks Price Volatility (%):
52 Weeks Range:2.65 - 4.21
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is a developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2383  1901  280  7747 

Top 10 Active Counters
 ISBC 13.87-0.35 
 DIDI 2.29-0.07 
 ENDP 0.43-0.093 
 AMD 76.86-1.13 
 CERN 94.920.00 
 AMZN 105.178-3.742 
 CCL 8.29-0.58 
 ENIA 4.81-0.24 
 AAPL 135.82-3.41 
 NVDA 151.895-3.525